Hereditary Angioedema Treatment Market
1 Introduction to Research & Analysis Reports
1.1 Hereditary Angioedema Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hereditary Angioedema Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hereditary Angioedema Treatment Overall Market Size
2.1 Global Hereditary Angioedema Treatment Market Size: 2021 VS 2028
2.2 Global Hereditary Angioedema Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hereditary Angioedema Treatment Sales: 2017-2028
3 Company Landscape
3.1 Top Hereditary Angioedema Treatment Players in Global Market
3.2 Top Global Hereditary Angioedema Treatment Companies Ranked by Revenue
3.3 Global Hereditary Angioedema Treatment Revenue by Companies
3.4 Global Hereditary Angioedema Treatment Sales by Companies
3.5 Global Hereditary Angioedema Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hereditary Angioedema Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hereditary Angioedema Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hereditary Angioedema Treatment Players in Global Market
3.8.1 List of Global Tier 1 Hereditary Angioedema Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Hereditary Angioedema Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hereditary Angioedema Treatment Market Size Markets, 2021 & 2028
4.1.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
4.1.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
4.1.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
4.1.5 Others (Conventional Drugs, Pipeline Drugs)
4.2 By Type - Global Hereditary Angioedema Treatment Revenue & Forecasts
4.2.1 By Type - Global Hereditary Angioedema Treatment Revenue, 2017-2022
4.2.2 By Type - Global Hereditary Angioedema Treatment Revenue, 2023-2028
4.2.3 By Type - Global Hereditary Angioedema Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Hereditary Angioedema Treatment Sales & Forecasts
4.3.1 By Type - Global Hereditary Angioedema Treatment Sales, 2017-2022
4.3.2 By Type - Global Hereditary Angioedema Treatment Sales, 2023-2028
4.3.3 By Type - Global Hereditary Angioedema Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Hereditary Angioedema Treatment Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Hereditary Angioedema Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Others (online pharmacies, mail pharmacies)
5.2 By Application - Global Hereditary Angioedema Treatment Revenue & Forecasts
5.2.1 By Application - Global Hereditary Angioedema Treatment Revenue, 2017-2022
5.2.2 By Application - Global Hereditary Angioedema Treatment Revenue, 2023-2028
5.2.3 By Application - Global Hereditary Angioedema Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Hereditary Angioedema Treatment Sales & Forecasts
5.3.1 By Application - Global Hereditary Angioedema Treatment Sales, 2017-2022
5.3.2 By Application - Global Hereditary Angioedema Treatment Sales, 2023-2028
5.3.3 By Application - Global Hereditary Angioedema Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Hereditary Angioedema Treatment Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Hereditary Angioedema Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hereditary Angioedema Treatment Revenue & Forecasts
6.2.1 By Region - Global Hereditary Angioedema Treatment Revenue, 2017-2022
6.2.2 By Region - Global Hereditary Angioedema Treatment Revenue, 2023-2028
6.2.3 By Region - Global Hereditary Angioedema Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Hereditary Angioedema Treatment Sales & Forecasts
6.3.1 By Region - Global Hereditary Angioedema Treatment Sales, 2017-2022
6.3.2 By Region - Global Hereditary Angioedema Treatment Sales, 2023-2028
6.3.3 By Region - Global Hereditary Angioedema Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Hereditary Angioedema Treatment Revenue, 2017-2028
6.4.2 By Country - North America Hereditary Angioedema Treatment Sales, 2017-2028
6.4.3 US Hereditary Angioedema Treatment Market Size, 2017-2028
6.4.4 Canada Hereditary Angioedema Treatment Market Size, 2017-2028
6.4.5 Mexico Hereditary Angioedema Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Hereditary Angioedema Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Hereditary Angioedema Treatment Sales, 2017-2028
6.5.3 Germany Hereditary Angioedema Treatment Market Size, 2017-2028
6.5.4 France Hereditary Angioedema Treatment Market Size, 2017-2028
6.5.5 U.K. Hereditary Angioedema Treatment Market Size, 2017-2028
6.5.6 Italy Hereditary Angioedema Treatment Market Size, 2017-2028
6.5.7 Russia Hereditary Angioedema Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Hereditary Angioedema Treatment Market Size, 2017-2028
6.5.9 Benelux Hereditary Angioedema Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Hereditary Angioedema Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Hereditary Angioedema Treatment Sales, 2017-2028
6.6.3 China Hereditary Angioedema Treatment Market Size, 2017-2028
6.6.4 Japan Hereditary Angioedema Treatment Market Size, 2017-2028
6.6.5 South Korea Hereditary Angioedema Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Hereditary Angioedema Treatment Market Size, 2017-2028
6.6.7 India Hereditary Angioedema Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Hereditary Angioedema Treatment Revenue, 2017-2028
6.7.2 By Country - South America Hereditary Angioedema Treatment Sales, 2017-2028
6.7.3 Brazil Hereditary Angioedema Treatment Market Size, 2017-2028
6.7.4 Argentina Hereditary Angioedema Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hereditary Angioedema Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Hereditary Angioedema Treatment Sales, 2017-2028
6.8.3 Turkey Hereditary Angioedema Treatment Market Size, 2017-2028
6.8.4 Israel Hereditary Angioedema Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Hereditary Angioedema Treatment Market Size, 2017-2028
6.8.6 UAE Hereditary Angioedema Treatment Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 CSL
7.1.1 CSL Corporate Summary
7.1.2 CSL Business Overview
7.1.3 CSL Hereditary Angioedema Treatment Major Product Offerings
7.1.4 CSL Hereditary Angioedema Treatment Sales and Revenue in Global (2017-2022)
7.1.5 CSL Key News
7.2 Pharming Group
7.2.1 Pharming Group Corporate Summary
7.2.2 Pharming Group Business Overview
7.2.3 Pharming Group Hereditary Angioedema Treatment Major Product Offerings
7.2.4 Pharming Group Hereditary Angioedema Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Pharming Group Key News
7.3 Shire plc (Takeda Pharmaceutical Company Limited)
7.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporate Summary
7.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
7.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Major Product Offerings
7.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Key News
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Corporate Summary
7.4.2 Ionis Pharmaceuticals Business Overview
7.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Major Product Offerings
7.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Ionis Pharmaceuticals Key News
7.5 Attune Pharmaceuticals
7.5.1 Attune Pharmaceuticals Corporate Summary
7.5.2 Attune Pharmaceuticals Business Overview
7.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Major Product Offerings
7.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Attune Pharmaceuticals Key News
7.6 BioCryst Pharmaceuticals
7.6.1 BioCryst Pharmaceuticals Corporate Summary
7.6.2 BioCryst Pharmaceuticals Business Overview
7.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Major Product Offerings
7.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales and Revenue in Global (2017-2022)
7.6.5 BioCryst Pharmaceuticals Key News
7.7 KalVista Pharmaceuticals
7.7.1 KalVista Pharmaceuticals Corporate Summary
7.7.2 KalVista Pharmaceuticals Business Overview
7.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Major Product Offerings
7.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales and Revenue in Global (2017-2022)
7.7.5 KalVista Pharmaceuticals Key News
8 Global Hereditary Angioedema Treatment Production Capacity, Analysis
8.1 Global Hereditary Angioedema Treatment Production Capacity, 2017-2028
8.2 Hereditary Angioedema Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Hereditary Angioedema Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hereditary Angioedema Treatment Supply Chain Analysis
10.1 Hereditary Angioedema Treatment Industry Value Chain
10.2 Hereditary Angioedema Treatment Upstream Market
10.3 Hereditary Angioedema Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hereditary Angioedema Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Hereditary Angioedema Treatment in Global Market
Table 2. Top Hereditary Angioedema Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Hereditary Angioedema Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Hereditary Angioedema Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Hereditary Angioedema Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Hereditary Angioedema Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Hereditary Angioedema Treatment Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Hereditary Angioedema Treatment Product Type
Table 9. List of Global Tier 1 Hereditary Angioedema Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hereditary Angioedema Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hereditary Angioedema Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Hereditary Angioedema Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Hereditary Angioedema Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Hereditary Angioedema Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Hereditary Angioedema Treatment Sales (K Units), 2023-2028
Table 16. By Application ? Global Hereditary Angioedema Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Hereditary Angioedema Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Hereditary Angioedema Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Hereditary Angioedema Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Hereditary Angioedema Treatment Sales (K Units), 2023-2028
Table 21. By Region ? Global Hereditary Angioedema Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Hereditary Angioedema Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Hereditary Angioedema Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Hereditary Angioedema Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Hereditary Angioedema Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Hereditary Angioedema Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Hereditary Angioedema Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Hereditary Angioedema Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Hereditary Angioedema Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Hereditary Angioedema Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Hereditary Angioedema Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Hereditary Angioedema Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Hereditary Angioedema Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Hereditary Angioedema Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Hereditary Angioedema Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Hereditary Angioedema Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Hereditary Angioedema Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Hereditary Angioedema Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Hereditary Angioedema Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Hereditary Angioedema Treatment Sales, (K Units), 2023-2028
Table 46. CSL Corporate Summary
Table 47. CSL Hereditary Angioedema Treatment Product Offerings
Table 48. CSL Hereditary Angioedema Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Pharming Group Corporate Summary
Table 50. Pharming Group Hereditary Angioedema Treatment Product Offerings
Table 51. Pharming Group Hereditary Angioedema Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Shire plc (Takeda Pharmaceutical Company Limited) Corporate Summary
Table 53. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Offerings
Table 54. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Ionis Pharmaceuticals Corporate Summary
Table 56. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Offerings
Table 57. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Attune Pharmaceuticals Corporate Summary
Table 59. Attune Pharmaceuticals Hereditary Angioedema Treatment Product Offerings
Table 60. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. BioCryst Pharmaceuticals Corporate Summary
Table 62. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Offerings
Table 63. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. KalVista Pharmaceuticals Corporate Summary
Table 65. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Offerings
Table 66. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Hereditary Angioedema Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 68. Global Hereditary Angioedema Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Hereditary Angioedema Treatment Production by Region, 2017-2022 (K Units)
Table 70. Global Hereditary Angioedema Treatment Production by Region, 2023-2028 (K Units)
Table 71. Hereditary Angioedema Treatment Market Opportunities & Trends in Global Market
Table 72. Hereditary Angioedema Treatment Market Drivers in Global Market
Table 73. Hereditary Angioedema Treatment Market Restraints in Global Market
Table 74. Hereditary Angioedema Treatment Raw Materials
Table 75. Hereditary Angioedema Treatment Raw Materials Suppliers in Global Market
Table 76. Typical Hereditary Angioedema Treatment Downstream
Table 77. Hereditary Angioedema Treatment Downstream Clients in Global Market
Table 78. Hereditary Angioedema Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hereditary Angioedema Treatment Segment by Type
Figure 2. Hereditary Angioedema Treatment Segment by Application
Figure 3. Global Hereditary Angioedema Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hereditary Angioedema Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hereditary Angioedema Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Hereditary Angioedema Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hereditary Angioedema Treatment Revenue in 2021
Figure 9. By Type - Global Hereditary Angioedema Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Hereditary Angioedema Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Hereditary Angioedema Treatment Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Hereditary Angioedema Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Hereditary Angioedema Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Hereditary Angioedema Treatment Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Hereditary Angioedema Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Hereditary Angioedema Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Hereditary Angioedema Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Hereditary Angioedema Treatment Sales Market Share, 2017-2028
Figure 19. US Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Hereditary Angioedema Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Hereditary Angioedema Treatment Sales Market Share, 2017-2028
Figure 24. Germany Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Hereditary Angioedema Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Hereditary Angioedema Treatment Sales Market Share, 2017-2028
Figure 33. China Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Hereditary Angioedema Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Hereditary Angioedema Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Hereditary Angioedema Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Hereditary Angioedema Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Hereditary Angioedema Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Hereditary Angioedema Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Hereditary Angioedema Treatment by Region, 2021 VS 2028
Figure 50. Hereditary Angioedema Treatment Industry Value Chain
Figure 51. Marketing Channels
Industry Market Size
